Premature Discontinuation of Dual Antiplatelet Therapy After Coronary Stenting in Veterans: Characteristics and Long‐Term Outcomes
Background Premature discontinuation of dual antiplatelet therapy (DAPT) after percutaneous coronary intervention is related to higher short‐term risks of adverse outcomes. Whether these risks persist in the long‐term is uncertain. Methods and Results We assessed all patients having percutaneous cor...
Main Authors: | Scott Kinlay, Lien Quach, Jean Cormack, Natalie Morgenstern, Ying Hou, Melissa Young, Rebecca Sherrod, Kelly Cho, David P. Faxon, Ronnie Ramadan, Michael Gaziano, David Gagnon |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2021-05-01
|
Series: | Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease |
Subjects: | |
Online Access: | https://www.ahajournals.org/doi/10.1161/JAHA.120.018481 |
Similar Items
-
Long‐Term Outcomes and Duration of Dual Antiplatelet Therapy After Coronary Intervention With Second‐Generation Drug‐Eluting Stents: The Veterans Affairs Extended DAPT Study
by: Scott Kinlay, et al.
Published: (2023-01-01) -
Importance of Short-Term Neointimal Coverage of Drug-Eluting Stents in the Duration of Dual Antiplatelet Therapy
by: Joanna Fluder-Wlodarczyk, et al.
Published: (2024-03-01) -
Fifteen-Year Nationwide Trend in Antiplatelet Treatment among Drug-Eluting Stent Recipients in Korea: Many Patients Receive Very Prolonged Dual-Antiplatelet Treatment, and Newer Drugs Are Replacing the Older Ones
by: Sunwon Kim, et al.
Published: (2023-04-01) -
Best duration of dual antiplatelet therapy after drug-eluting stent implantation: an updated network meta-analysis of randomized controlled trials
by: Mahmoud Barbarawi, et al.
Published: (2019-01-01) -
Trends in antiplatelet strategies 12-months following coronary stent placement in anticoagulated patients
by: Eleni M. Gamvroulas, et al.
Published: (2023-03-01)